Records containing: Recurrent Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-24Testing the Efficacy of Indocyanine Green Imaging (ICG-SPY) in the Identification of Sentinel Lymph Nodes (SLN) in Patients With Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2017-04-19Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-04-13FDG-PET/CT as a Biomarker for Treatment Response in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-17Phase II Trial Evaluating Resection Followed By Adjuvant Radiation Therapy (RT) For Patients With Desmoplastic Melanoma
-
CLINICAL_TRIALS study record update · 2017-03-03A Phase I/II Study of Intratumoral Injection of Ipilimumab in Combination With Local Radiation in Melanoma, Non-Hodkgkin Lymphoma and Colorectal Carcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-02-20A Randomized Phase II Trial to Determine the Immune Response to a Mutated gp100 Melanoma Peptide (209-2M) Vaccine in HLA-A2 Positive Patients With a >1mm Melanoma on Initial Biopsy
-
CLINICAL_TRIALS study record update · 2017-02-15Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2016-10-24A Randomized Phase II Study of Multipeptide Vaccination With or Without IL-12, Then Combined With Regulatory T Cell Depletion Using Daclizumab in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2016-10-04A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-07-22A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2016-06-14Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2016-05-30A Phase II Correlative Clinical Trial of MLN8237, a Selective Aurora Kinase A (AURKA) Inhibitor, in Patients With Unresectable Stage III or Stage IV Melanoma Disease
-
CLINICAL_TRIALS study record update · 2016-03-17A Phase 2 Study of Bevacizumab and Interferon-Alpha-2b in Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-10-02Phase II Trial Of Interferon-B In Patients With Metastatic Cutaneous Melanoma And Metastatic Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2015-08-11Phase II Trial of Hyd-sulfate AZD6244 [NSC 748727] in Patients With BRAF or NRAS Mutated Melanomas
-
CLINICAL_TRIALS study record update · 2015-07-23Isolated Limb Perfusion for Advanced Melanoma or Sarcoma Limited to Extremity With or Without Distant Metastases
-
CLINICAL_TRIALS study record update · 2015-06-23A Phase II Study of AZD2171 in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-04-15Phase 2 Study of the Combination of BAY 43-9006 (Sorafenib) and CCI-779 (Temsirolimus) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-04-02A Phase II Trial of GM-CSF Protein Plus Ipilimumab in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2015-03-02A Phase II Study of UCN-01 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-02-06Two Phase I Studies in Patients With Brain Metastases From Any Primary Histology, Followed by a Randomized Phase 2 Study of RO4929097 Combined With CNS Radiotherapy in Patients With Brain Metastases From Breast Cancer Whose Tumors Are Estrogen Receptor Negative
-
CLINICAL_TRIALS study record update · 2015-02-04A Phase 2 Study Evaluating the Efficacy of VEGF Trap in Patients With Recurrent Inoperable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-01-26A Pilot Study to Assess the Immunologic Response to Booster Vaccination With a Modified gp100 Melanoma Peptide (209-2M) Vaccine in Previously Vaccinated HLA-A2.1+ Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2014-12-23A Phase II Study of Imatinib Mesylate (STI571;NSC#716051:IND 61135) in Patients With Inoperable AJCC Stage III or IV Melanoma Harboring Somatic Alterations of C-KIT
-
CLINICAL_TRIALS study record update · 2014-12-23A Phase 1, Pharmacokinetic and Pharmacodynamic Study of the Combination of RO4929097 and Cediranib in Patients With Advanced Solid Tumors